Cell line · CVCL_8787
WM793
Cancer cell line, Homo sapiens. Cutaneous melanoma. 42 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. WM793. Cell lines, record CVCL_8787. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_8787
On this page
Cell line
As Cellosaurus gives it.
- Name
- WM793
- Accession
- CVCL_8787
- RRID
- RRID:CVCL_8787
- Synonyms
- WM-793, WM 793, WML 793, WM793B, WM-793B, WM 793B, WM793b, WC00062
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 37Y
- Category
- Cancer cell line
- Diseases
- Cutaneous melanoma (NCIt C3510)
- Derived from
- Skin (in situ)
- Secondary accessions
- CVCL_5414
- Entry created
- 2012-06-06
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 11,14->14,15. |
Source Cellosaurus
Papers42
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity. | Cell Commun Signal | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Emerging role of ARHGAP29 in melanoma cell phenotype switching. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma. | Cell Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Human CSPG4-targeting CAR-macrophages inhibit melanoma growth. | Oncogene | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. | Genes Dev | 2025 | Its Methods give the RRID and name the line | PubMed | |
| GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| C19MC drives nucleolar invasion of mitochondria and meiotic nuclear division in human cancers. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 42
See all 42 papersRelatives7
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | 1205Lu | CVCL_5239 | Has a recorded problem | Cell lines |
| Derived from it | WM793-P1N1 | CVCL_A800 | Cell lines | |
| Derived from it | WM793-P1N2 | CVCL_A801 | Cell lines | |
| Derived from it | WM793-P1N3 | CVCL_A802 | Cell lines | |
| Derived from it | WM793-P2N1 | CVCL_A803 | Cell lines | |
| Derived from it | WM793-P2N2 | CVCL_A804 | Cell lines | |
| Derived from it | WM793-P2N3 | CVCL_A805 | Cell lines |
Cell banks2
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | CRL-2806 | Discontinued |
| Coriell | WC00062 | Discontinued |
Source Cellosaurus
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_8787
GET https://conductscience.org/api/cell-lines/v1/CVCL_8787/papers?page=2